The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer's disease
Abstract
Interest in characterizing the role of impaired insulin actions in Alzheimer's disease (AD) and vascular dementia is growing exponentially. This review details what is currently known about insulin, insulin-like growth factor type I (IGF-I) and IGF-II proteins and their corresponding receptors in the brain, and delineates the major controversies pertaining to alterations in the expression and function of these molecules in AD. The various experimental animal models generated by over-expression, mutation, or depletion of genes that are critical to the insulin or IGF signaling cascades are summarized, noting the degrees to which they reproduce the histopathological, biochemical, molecular, or behavioral abnormalities associated with AD. Although no single model was determined to be truly representative of AD, depletion of the neuronal insulin receptor and intracerebroventricular injection of Streptozotocin reproduce a number of important aspects of AD-type neurodegeneration, and therefore provide supportive evidence that AD may be caused in part by neuronal insulin resistance, i.e. brain diabetes. The extant literature did not resolve whether the CNS insulin resistance in AD represents a local disease process, or complication/extension of peripheral insulin resistance, i.e. chronic hyperglycemia, hyperinsulinemia, and Type 2 diabetes mellitus. The available epidemiological data are largely inconclusive with regard to the contribution of Type 2 diabetes mellitus to cognitive impairment and AD-type neurodegeneration. A major conclusion drawn from this review is that there is a genuine need for thorough and comprehensive study of the neuropathological changes associated with diabetes mellitus, in the presence or absence of superimposed AD or vascular dementia. Strategies for intervention may depend entirely upon whether the CNS disease processes are mediated by peripheral, central, or both types of insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y.-C., Tsubokawa, M., et al. (1985) · Nature · doi:10.1038/313756a0 · Cited by 2,251
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
Burgering, B. M. T., & Coffer, P. J. (1995) · Nature · doi:10.1038/376599a0 · Cited by 2,089
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration
Patrick, G. N., Zukerberg, L., Nikolic, M., de la Monte, S., Dikkes, P., & Tsai, L.-H. (1999) · Nature · doi:10.1038/45159 · Cited by 1,545
Self-citationFarris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J., & Dedhar, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11211 · Cited by 1,092
Kulik, G., Klippel, A., & Weber, M. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1595 · Cited by 1,040
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway
Pap, M., & Cooper, G. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19929 · Cited by 1,040
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854 · cited 1×
“In addition, genetic depletion of IRS-2 impairs neuronal proliferation during development, and promotes accumulation of phosphorylated tau containing neurofibrillary tangles in the hippocampi of affected old mice [52, 53].”
BackgroundInsulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation
Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., & Selkoe, D. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32730 · Cited by 812
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748
Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 719
Association of diabetes mellitus and dementia, the Rotterdam study
Ott, A., Stolk, R. P., Hofman, A., van Harskamp, F., Grobbee, D. E., & Breteler, M. M. B. (1996) · Diabetologia · doi:10.1007/s001250050588 · Cited by 677
Role for neuronal insulin resistance in neurodegenerative diseases
Schubert, M., Gautam, D., Surjo, D., Ueki, K., Baudler, S., Schubert, D., Kondo, T., Alber, J., Galldiks, N., Küstermann, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308724101 · Cited by 637
Insulin signaling pathways in time and space
Saltiel, A. R., & Pessin, J. E. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02207-3 · Cited by 628
Craft, S., Peskind, E., Schwartz, M. W., Schellenberg, G. D., Raskind, M., & Porte, D. (1998) · Neurology · doi:10.1212/wnl.50.1.164 · Cited by 560
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Nakae, J., Kido, Y., & Accili, D. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.6.0452 · Cited by 554
Memory improvement following induced hyperinsulinemia in Alzheimer’s disease
Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., Luby, J., Dagogo-Jack, A., & Alderson, A. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02002-0 · Cited by 538 · cited 1×
“However, further studies demonstrated that patients with very early AD, but not those in the late stages of disease, exhibited significant improvements in memory following a rapid therapeutic increase in plasma glucose to 225 mg/dl, with an accompanying increase in plasma insulin [79,80].”
BackgroundLannert, H., & Hoyer, S. (1998) · Behavioral Neuroscience · doi:10.1037//0735-7044.112.5.1199 · Cited by 525
Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons
Hong, M., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 522
Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10q
Bertram, L., Blacker, D., Mullin, K., Keeney, D., Jones, J., Basu, S., Yhu, S., McInnis, M. G., Go, R. C. P., Vekrellis, K., et al. (2000) · Science · doi:10.1126/science.290.5500.2302 · Cited by 519
Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI
den Heijer, T., Vermeer, S. E., van Dijk, E. J., Prins, N. D., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2003) · Diabetologia · doi:10.1007/s00125-003-1235-0 · Cited by 514
Vekrellis, K., Ye, Z., Qiu, W. Q., Walsh, D., Hartley, D., Chesneau, V., Rosner, M. R., & Selkoe, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01657.2000 · Cited by 495
Gasparini, L., Gouras, G. K., Wang, R., Gross, R. S., Beal, M. F., Greengard, P., & Xu, H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02561.2001 · Cited by 492
Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation
Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., Farhang-Fallah, J., Dikkes, P., Warot, X. M., Rio, C., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07084.2003 · Cited by 488
Carson, M. J., Behringer, R. R., Brinster, R. L., & McMorris, F. A. (1993) · Neuron · doi:10.1016/0896-6273(93)90173-o · Cited by 474
Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.-M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., et al. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00246-3 · Cited by 469
Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1.
Sun, X. J., Crimmins, D. L., Myers, M. G., Miralpeix, M., & White, M. F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7418 · Cited by 466
The role of the insulin-like growth factors in the central nervous system
D’Ercole, A. J., Ye, P., Calikoglu, A. S., & Gutierrez-Ospina, G. (1996) · Molecular Neurobiology · doi:10.1007/bf02740625 · Cited by 447
Role of Glycogen Synthase Kinase-3β in Neuronal Apoptosis Induced by Trophic Withdrawal
Hetman, M., Cavanaugh, J. E., Kimelman, D., & Xia, Z. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02567.2000 · Cited by 440
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
Hoyer, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.049 · Cited by 434
Kuusisto, J., Koivisto, K., Mykkänen, L., Helkala, E.-L., Vanhanen, M., Hänninen, T., Kervinen, K., Kesäniemi, Y. A., Riekkinen, P. J., & Laakso, M. (1997) · BMJ · doi:10.1136/bmj.315.7115.1045 · Cited by 429
Glycogen synthase kinase 3: a drug target for CNS therapies
Bhat, R. V., Budd Haeberlein, S. L., & Avila, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02422.x · Cited by 408
UNGER, J., LIVINGSTON, J., & MOSS, A. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90015-s · Cited by 404
Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses
Mandelkow, E. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.007 · Cited by 401
The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease
Zhu, X., Lee, H.-G., Raina, A. K., Perry, G., & Smith, M. A. (2002) · Neurosignals · doi:10.1159/000067426 · Cited by 391
Essential Role for Protein Kinase B (PKB) in Insulin-induced Glycogen Synthase Kinase 3 Inactivation
van Weeren, P. C., de Bruyn, K. M. T., de Vries-Smits, A. M. M., van Lint, J., & Burgering, B. M. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.13150 · Cited by 365
O'Kusky, J. R., Ye, P., & D'Ercole, A. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08435.2000 · Cited by 358
Cook, D. G., Leverenz, J. B., McMillan, P. J., Kulstad, J. J., Ericksen, S., Roth, R. A., Schellenberg, G. D., Jin, L.-W., Kovacina, K. S., & Craft, S. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63822-9 · Cited by 331
Glucose and lactate metabolism during brain activation
Dienel, G. A., & Hertz, L. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10079 · Cited by 328
Doré, S., Kar, S., & Quirion, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4772 · Cited by 325
Chih, C.-P., & Roberts, E. L. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000081369.51727.6f · Cited by 325
Halestrap, A. P., Doran, E., Gillespie, J. P., & O'Toole, A. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280170 · Cited by 321
Myers, M. G., Sun, X. J., & White, M. F. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90007-8 · Cited by 315
Does insulin dysfunction play a role in Alzheimer's disease?
Gasparini, L. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02037-0 · Cited by 314
Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose
Craft, S., Asthana, S., Newcomer, J. W., Wilkinson, C. W., Matos, I. T., Baker, L. D., Cherrier, M., Lofgreen, C., Latendresse, S., Petrova, A., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1135 · Cited by 312
Alzheimer's β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor
Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., van Bronswijk, W., & Martins, R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-10-j0001.2002 · Cited by 291
Wnt signaling function in Alzheimer’s disease
De Ferrari and, G. V., & Inestrosa, N. C. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00021-7 · Cited by 289
de la Torre, J. C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00111-1 · Cited by 284
Farris, W., Mansourian, S., Leissring, M. A., Eckman, E. A., Bertram, L., Eckman, C. B., Tanzi, R. E., & Selkoe, D. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63229-4 · Cited by 269
Hoyer, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050067 · Cited by 265
Craft, S., Asthana, S., Cook, D. G., Baker, L. D., Cherrier, M., Purganan, K., Wait, C., Petrova, A., Latendresse, S., Watson, G. S., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00087-2 · Cited by 255
Pérez, A., Morelli, L., Cresto, J. C., & Castaño, E. M. (2000) · Neurochemical Research · doi:10.1023/a:1007527721160 · Cited by 240
Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes
Messier, C., & Gagnon, M. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00153-0 · Cited by 237
Brain Insulin: Regulation, Mechanisms of Action and Functions
Gerozissis, K. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1022598900246 · Cited by 234
Lam, K., Carpenter, C. L., Ruderman, N. B., Friel, J. C., & Kelly, K. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32042-2 · Cited by 232
Pei, J.-J., Grundke-Iqbal, I., Iqbal, K., Bogdanovic, N., Winblad, B., & Cowburn, R. F. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00296-0 · Cited by 226 · cited 1×
“The major kinases responsible for physiological phosphorylation of tau include: Erk MAPK and cyclin dependent kinase 5 (Cdk-5), both of which are activated by insulin and IGF-1 [104–106].”
BackgroundThe role of PI 3-kinase in insulin action
Alessi, D. R., & Downes, C. P. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s0005-2760(98)00133-7 · Cited by 220
Nishimura, M., Yu, G., Levesque, G., Zhang, D. M., Ruel, L., Chen, F., Milman, P., Holmes, E., Liang, Y., Kawarai, T., et al. (1999) · Nature Medicine · doi:10.1038/5526 · Cited by 219
Mutant mouse models of insulin-like growth factor actions in the central nervous system
D'Ercole, J. A., Ye, P., & O'Kusky, J. R. (2002) · Neuropeptides · doi:10.1054/npep.2002.0893 · Cited by 209
The cellular and physiological actions of insulin in the central nervous system
Wozniak, M., Rydzewski, B., Baker, S. P., & Raizada, M. K. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90062-a · Cited by 207
The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update
Hoyer, S. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200028 · Cited by 205
Crossthwaite, A. J., Hasan, S., & Williams, R. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00637.x · Cited by 201
Hoyer, S., Nitsch, R., & Oesterreich, K. (1991) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02251132 · Cited by 196
Craft, S., Dagogo-Jack, S. E., Wiethop, B. V., Murphy, C., Nevins, R. T., Fleischman, S., Rice, V., Newcomer, J. W., & Cryer, P. E. (1993) · Behavioral Neuroscience · doi:10.1037/0735-7044.107.6.926 · Cited by 191
CRAFT, S., ASTHANA, S., SCHELLENBERG, G., BAKER, L., CHERRIER, M., BOYT, A. A., MARTINS, R. N., RASKIND, M., PESKIND, E., & PLYMATE, S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06371.x · Cited by 191
Eves, E. M., Xiong, W., Bellacosa, A., Kennedy, S. G., Tsichlis, P. N., Rosner, M. R., & Hay, N. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.2143 · Cited by 188
McDermott, J. R., & Gibson, A. M. (1997) · Neurochemical Research · doi:10.1023/a:1027325304203 · Cited by 187
Energy transfer from astrocytes to axons: the role of CNS glycogen
Brown, A. M., Baltan Tekkök, S., & Ransom, B. R. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.11.005 · Cited by 186
Insulin-Mediated Regulation of Neuronal Maturation
Puro, D. G., & Agardh, E. (1984) · Science · doi:10.1126/science.6089343 · Cited by 181
Plaschke, K., & Hoyer, S. (1993) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(93)90021-5 · Cited by 178
Mill, J. F., Chao, M. V., & Ishii, D. N. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7126 · Cited by 176
Hoyer, S. (2004) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-8969-7_8 · Cited by 174
Hoyer, S. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00156-x · Cited by 174
Heitner, J., & Dickson, D. (1997) · Neurology · doi:10.1212/wnl.49.5.1306 · Cited by 171
Biogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptides
Evin, G., & Weidemann, A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00063-3 · Cited by 170
Peroxisome Proliferator-Activated Receptor (PPAR)-α Activation Prevents Diabetes in OLETF Rats
Koh, E. H., Kim, M.-S., Park, J., Kim, H. S., Youn, J. Y., Park, H., Youn, J. H., & Lee, K. (2003) · Diabetes · doi:10.2337/diabetes.52.9.2331 · Cited by 167
Akt activity in Alzheimer’s disease and other neurodegenerative disorders
Rickle, A., Bogdanovic, N., Volkman, I., Winblad, B., Ravid, R., & Cowburn, R. F. (2004) · NeuroReport · doi:10.1097/00001756-200404290-00005 · Cited by 166
Role of protein kinase B in Alzheimer's neurofibrillary pathology
Pei, J.-J., Khatoon, S., An, W.-L., Nordlinder, M., Tanaka, T., Braak, H., Tsujio, I., Takeda, M., Alafuzoff, I., Winblad, B., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0657-y · Cited by 165
Popken, G. J., Hodge, R. D., Ye, P., Zhang, J., Ng, W., O'Kusky, J. R., & D'Ercole, A. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03320.x · Cited by 164
Hoyer, S. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200082 · Cited by 161
A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease
FRÖLICH, L., BLUM‐DEGEN, D., RIEDERER, P., & HOYER, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07839.x · Cited by 160
Ye, P., Xing, Y., Dai, Z., & D'Ercole, A. J. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(96)00492-0 · Cited by 159
Moroo, I., Yamada, T., Makino, H., Tooyama, I., McGeer, P. L., McGeer, E. G., & Hirayama, K. (1994) · Acta Neuropathologica · doi:10.1007/bf00313602 · Cited by 159
Tham, A., Nordberg, A. K., Grissom, F. E., Carlsson‐Skwirut, C., Viitanen, M. H., & Sara, V. R. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257671 · Cited by 155
Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender
Craft, S., Asthana, S., Schellenberg, G., Cherrier, M., Baker, L. D., Newcomer, J., Plymate, S., Latendresse, S., Petrova, A., Raskind, M., et al. (1999) · Neuroendocrinology · doi:10.1159/000054469 · Cited by 154
Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential
Giovannone, B., Scaldaferri, M. L., Federici, M., Porzio, O., Lauro, D., Fusco, A., Sbraccia, P., Borboni, P., Lauro, R., & Sesti, G. (2000) · Diabetes/Metabolism Research and Reviews · doi:10.1002/1520-7560(2000)9999:9999<::aid-dmrr159>3.0.co;2-8 · Cited by 150
Duelli, R., Schröck, H., Kuschinsky, W., & Hoyer, S. (1994) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(94)90053-1 · Cited by 150
Changes in Blood Glucose and Insulin Secretion in Patients with Senile Dementia of Alzheimer Type
Bucht, G., Adolfsson, R., Lithner, F., & Winblad, B. G. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb03756.x · Cited by 147
Hoyer, S., & Nitsch, R. M. (1989) · Journal of Neural Transmission · doi:10.1007/bf01258634 · Cited by 146
Mitochondrial permeability transition in apoptosis and necrosis
Hirsch, T., Susín, S. A., Marzo, I., Marchetti, P., Zamzami, N., & Kroemer, G. (1998) · Cell Biology and Toxicology · doi:10.1023/a:1007486022411 · Cited by 143
de la Monte, S. M., & Wands, J. R. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8475-x · Cited by 135
Self-citationRosiglitazone Improves Downstream Insulin Receptor Signaling in Type 2 Diabetic Patients
Miyazaki, Y., He, H., Mandarino, L. J., & DeFronzo, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1943 · Cited by 135
Poduslo, J. F., Curran, G. L., Wengenack, T. M., Malester, B., & Duff, K. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0402 · Cited by 131
Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures
Egaña, J. T., Zambrano, C. A., Núñez, M. T., González-Billault, C. E., & Maccioni, R. B. (2003) · BioMetals · doi:10.1023/a:1020727218493 · Cited by 126
Caspase Cleavage Enhances the Apoptosis-Inducing Effects of BAD
Condorelli, F., Salomoni, P., Cotteret, S., Cesi, V., Srinivasula, S. M., Alnemri, E. S., & Calabretta, B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3025-3036.2001 · Cited by 125
Chen, G., Xu, X. J., Lahousse, S. A., Caggiano, N. L., & de la Monte, S. M. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5305 · Cited by 123
Fujisawa, Y., Sasaki, K., & Akiyama, K. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90158-i · Cited by 123
Hyperinsulinaemia and Alzheimer's Disease
Razay, G., & Wilcock, G. K. (1994) · Age and Ageing · doi:10.1093/ageing/23.5.396 · Cited by 123
Zheng, W., Kar, S., Doré, S., & Quirion, R. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_17 · Cited by 122
Bernstein, H., Ansorge, S., Riederer, P. F., Reiser, M., Frölich, L., & Bogerts, B. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00135-4 · Cited by 115
Diabetes, Alzheimer's disease and apolipoprotein genotype
Messier, C. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00153-0 · Cited by 105
Desensitization of brain insulin receptor Effect on glucose/energy and related metabolism
Hoyer, S., Müller, D., & Plaschke, K. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_20 · Cited by 104
de la Monte, S. M., Ganju, N., Banerjee, K., Brown, N. V., Luong, T., & Wands, J. R. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02044.x · Cited by 104
Self-citationAbraham, R., Myers, A., Wavrant-DeVrièze, F., Hamshere, M. L., Thomas, H. V., Marshall, H. N., Compton, D., Spurlock, G., Turic, D., Hoogendoorn, B., et al. (2001) · Human Genetics · doi:10.1007/s00439-001-0614-1 · Cited by 99
The role of the metabolic lesion in Alzheimer's disease
Blass, J. P., Gibson, G. E., & Hoyer, S. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4312 · Cited by 90
Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease
Hoyer, S. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05868.x · Cited by 88 · cited 1×
“zation of the neuronal insulin receptor [151–154].”
Inhibition of the Neuronal Insulin Receptor An in Vivo Model for Sporadic Alzheimer Disease?
Hoyer, S., Lee, S. K., Löffler, T., & Schliebs, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06932.x · Cited by 87
Hoyer, S., & Lannert, H. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07842.x · Cited by 87
Mustafa, A., Lannfelt, L., Lilius, L., Islam, A., Winblad, B. G., & Adem, A. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017188 · Cited by 86
Tsukamoto, E., Hashimoto, Y., Kanekura, K., Niikura, T., Aiso, S., & Nishimoto, I. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10703 · Cited by 86
Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance
Mauvais‐Jarvis, F., Kulkarni, R., & Kahn, C. R. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01563.x · Cited by 85
Pete, G., Fuller, C. R., Oldham, J. M., Smith, D. R., Ercole, A., Kahn, C. R., & Lund, P. K. (1999) · Endocrinology · doi:10.1210/endo.140.12.7219 · Cited by 82
Alterations in Glucose Metabolism in Patients with Alzheimer's Disease
Meneilly, G. S., & Hill, A. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb07458.x · Cited by 81
Folli, F. B., Ghidella, S., Bonfanti, L., Kahn, C. R., & Merighi, A. (1996) · Molecular Neurobiology · doi:10.1007/bf02740639 · Cited by 80
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease
ETIENNE, D., Kraft, J., Ganju, N., Gómez‐Isla, T., Gemelli, B., Hyman, B. T., Hedley‐Whyte, E. T., Wands, J. R., & de la Monte, S. M. (1998) · Journal of Alzheimer s Disease · doi:10.3233/jad-1998-1205 · Cited by 76
Self-citationDentremont, K. D., Ye, P., D’Ercole, A. J., & OʼKusky, J. R. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(99)00024-3 · Cited by 76
Ethanol impairs insulin-stimulated mitochondrial function in cerebellar granule neurons
de la Monte, S. M., Neely, T. R., Cannon, J., & Wands, J. R. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000829 · Cited by 76
Self-citationNi, W., Rajkumar, K., Nagy, J. I., & Murphy, L. J. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00676-8 · Cited by 74
Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease
Boussaha, M., Hannequin, D., Verpillat, P., Brice, A., Frébourg, T., & Campion, D. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00586-4 · Cited by 70
Kuperstein, F., & Yavin, E. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02056.x · Cited by 67
Connor, B. J., Beilharz, E. J., Williams, C., Synek, B. J., Gluckman, P. D., Faull, R. L. M., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00192-7 · Cited by 67
Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor
Xie, L., Martins, R. N., Racchi, M., Craft, S., & Helmerhorst, E. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4504 · Cited by 61
Characterization of H2O2‐induced acute apoptosis in cultured neural stem/progenitor cells
Lin, H. J., Wang, X., Shaffer, K. M., Sasaki, C. Y., & Ma, W. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.06.019 · Cited by 61
Mauvais‐Jarvis, F., & Kahn, C. R. (2000) · PubMed · Cited by 59
Ye, P., Umayahara, Y., Ritter, D. G., Bunting, T. A., Auman, H. J., Rotwein, P. S., & D’Ercole, A. J. (1997) · Endocrinology · doi:10.1210/en.138.12.5466 · Cited by 56
Alzheimer Disease and Vascular Dementia: Relationships with Fasting Glucose and Insulin Levels
Carantoni, M., Zuliani, G., Munari, M. R., D’Elia, K., Palmieri, E., & Fellin, R. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017232 · Cited by 56
Heidenreich, K. A., & TOLEDO, S. P. (1989) · Endocrinology · doi:10.1210/endo-125-3-1451 · Cited by 56
Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?
Blum-Degen, D., Frölich, L., Hoyer, S., & Riederer, P. F. (1995) · PubMed · Cited by 55
Expression of Insulin‐like Growth Factor‐I in Transgenic Micea
D’Ercole, A. J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26213.x · Cited by 55
Jafferali, S., Dumont, Y., Sotty, F., Robitaille, Y., Quirion, R., & Kar, S. (2000) · Synapse · doi:10.1002/1098-2396(20001215)38:4<450::aid-syn10>3.0.co;2-j · Cited by 54
Pro‐apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity
Kuperstein, F., & Yavin, E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01831.x · Cited by 52
Doré, S., Bastianetto, S., Kar, S., & Quirion, R. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08015.x · Cited by 52
Alzheimer's disease linking neurodegeneration with neurodevelopment.
Grilli, M., Ferrari‐Toninelli, G., Uberti, D. L., Spano, P., & Memo, M. (2003) · PubMed · Cited by 51
Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease
Pérez-Molina, J. A., Jiménez-Jiménez, F. J., Vargas, C., Gómez, P. A., de Bustos, F., Gómez-Escalonilla, C., Zurdo, M., Tallón-Barranco, A., Martínez‐Salio, A., Porta-Etessam, J., et al. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.01326.x · Cited by 46
Effects of Age on Elements of Insulin-Signaling Pathway in Central Nervous System of Rats
Fernandes, M. L. D. L. A., Saad, M. J. A., & Velloso, L. A. (2001) · Endocrine · doi:10.1385/endo:16:3:227 · Cited by 42
Ye, P., Li, L., Lund, P. K., & D’Ercole, A. J. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00355-3 · Cited by 42
Doublier, S., Duyckaerts, C. J., Seurin, D., & Binoux, M. (2000) · Growth Hormone & IGF Research · doi:10.1054/ghir.2000.0168 · Cited by 41
Keyser, J. D., Wilczak, N., & Goossens, A. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90670-x · Cited by 40
Nutritional Status of Patients with Alzheimer's Disease
Spindler, A. A., Renvall, M. J., Nichols, J. F., & Ramsdell, J. (1996) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(96)00270-2 · Cited by 39
Insulin‐Like Growth Factor I Receptor Binding in Brains of Alzheimer's and Alcoholic Patients
Crews, F. T., McElhaney, R., Freund, G., Ballinger, W. E., & Raizada, M. K. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb11330.x · Cited by 39
Age as Risk Factor for Sporadic Dementia of the Alzheimer Type?
HOYER, S. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb56833.x · Cited by 38 · cited 1×
“zation of the neuronal insulin receptor [151–154].”
Confirmation of association between D10S583 and Alzheimer's disease in a case–control sample
Ait‐Ghezala, G., Abdullah, L. I., Crescentini, R. M., Crawford, F., Town, T., Singh, S., Richards, D., Duara, R., & MULLAN, M. J. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00243-4 · Cited by 38
Garver, T. D., Oyler, G. A., Harris, K. A., Polavarapu, R., Damuni, Z., Lehman, R. A. W., & Billingsley, M. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08622-5 · Cited by 36
de la Monte, S. M., & Wands, J. R. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6304 · Cited by 31
Self-citationPresenilin function: connections to Alzheimer's disease and signal transduction
Fraser, P. E., Yu, G., Lévesque, L., Nishimura, M., Yang, D.-S., Mount, H. T. J., Westaway, D. A., & George‐Hyslop, P. S. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670089 · Cited by 31
Insulin Resistant States and Insulin Signaling
Vollenweider, P. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.173 · Cited by 30
Shpakov, A. O., & Pertseva, M. N. (2000) · PubMed · Cited by 28
Peripheral glucose metabolism and insulin sensitivity in Alzheimer's disease
Kilander, L., Boberg, M., & Lithell, H. (1993) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1993.tb05511.x · Cited by 26
Metabolic Changes in Alzheimer's Disease
Fisman, M., Gordon, B. A., Feleki, V., Helmes, E., McDonald, T. J., & Dupre, J. (1988) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1988.tb02354.x · Cited by 25
Zhong, J., Deng, J., Ghetti, B. F., & Lee, W. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10360 · Cited by 24
Kelicen, P., Cantuti‐Castelvetri, I., Pekiner, C., & Paulson, K. E. (2002) · Neuroreport · doi:10.1097/00001756-200206120-00016 · Cited by 20
Somatostatin and Alzheimer's disease: a hypothesis
Reubi, J. C., & Palacios, J. M. (1986) · Journal of Neurology · doi:10.1007/bf00313925 · Cited by 17
Tham, A., Björkstén, K. S., Bowen, D. M., Wetterberg, L., & Sara, V. R. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb05193.x · Cited by 13
Amyloid Beta Peptide Processing, Insulin Degrading Enzyme, and Butyrylcholinesterase
Balasubramanian, A. S. (2001) · Neurochemical Research · doi:10.1023/a:1010967602362 · Cited by 10
Tissue-Specific Targeting of the Insulin Receptor Gene
Kulkarni, R., & Okada, T. (2002) · Endocrine · doi:10.1385/endo:19:3:257 · Cited by 9
Cited by
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Self-citationMoloney, A. M., Griffin, R. J., Timmons, S., O’Connor, R., Ravid, R., & O’Neill, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.002 · Cited by 764
Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723
Is Alzheimer’s disease a type 3 diabetes? A critical appraisal
Kandimalla, R., Thirumala, V., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.08.018 · Cited by 621
Metadata
- Authors
- de la Monte, S. M., & Wands, J. R.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2005-03-03
- Volume
- 7
- Issue
- 1
- Pages
- 45-61
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2097157695
- Cited by
- 553
- References
- 160
- FWCI
- 12.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.